HOUSTON (ICIS)--Problems at a Pemex ammonia plant caused volumes and margins to decline at Alpek's sole caprolactam plant, the head of the Mexico-based resin producer said on Friday. Alpek produces caprolactam through its subsidiary Univex. The plant, in Salamanca, Mexico, has a capacity of 85,000 tonnes/year, according to ICIS plants and projects. For the past year, Univex has been operating the plant at 65-66% capacity because Pemex has not been operating its ammonia plant at full capacity, said Jose de Jesus Valdez, general director of Alpek. He made his comments during an earnings conference call.
展开▼
机译：休斯顿（ICIS） - 墨西哥树脂生产商负责人在星期五表示，疫苗氨植物的问题导致Alpek的唯一己内酰胺植物造成的卷和利润率下降。 Alpek通过其子公司Univex产生己内酰胺。 根据ICIS植物和项目的说法，墨西哥萨拉曼卡的植物容量为85,000吨/年。 在Alpek总经理Jose de Jesus Valdez表示，在过去的一年里，Univex一直以65-66％的能力运营植物，因为Pemex并未以全部能力运营氨植物。 他在收入电话会议期间提出了评论。
展开▼
